Global Market for Imaging CRO is Anticipated to grow at a Significant Pace i.e., USD 8.8 Billion during the Forecast Period 2021-2027


Posted March 22, 2022 by vynzresearch2reportindustry

VynZ Research is a global market intelligence company providing research reports.

 
The global imaging CRO market is growing rapidly at a CAGR of 7.1% during the forecast period 2021-2027. The rising number of clinical trials, development in the pharmaceutical industry, mounting awareness towards process automation, increased demand for high precision in drug manufacturing, and growing dependence of biotechnology and pharmaceutical companies on the CROs to conduct imaging trials will propel the growth of the global imaging CRO market.

In September 2021, the world's premier ophthalmology imaging core lab, Digital Angiography Reading Center (DARC), has been acquired by WorldCare Clinical (WCC), a worldwide imaging core lab situated in New York. Age-Related Macular Degeneration, Diabetic Retinopathy, Branch and Central Vein Occlusion, Choroidal Melanoma, Uveitis, PCV, and Retinitis Pigmentosa are just a few of the problems that DARC has studied.

Download Free Sample Copy Of Research Report: https://www.vynzresearch.com/healthcare/imaging-cro-market/request-sample

During the first wave of the pandemic, most regions were under strict lockdown, and clinical trial operations that included imaging were deemed non-essential. With an increase in clinical studies, particularly for COVID-19, the market is predicted to normalize in the first half of 2021. During the pandemic, the number of clinical trials for COVID-19 treatment and vaccine development increased dramatically. In the coming years, the development of new vaccines and treatment regimens is projected to increase demand for imaging CRO.

The biotechnology and pharmaceutical companies are anticipated to have significant growth owing to the rising demand for developing novel drugs and therapies to cure chronic and severe diseases. As biotechnology and pharmaceutical companies continue to make ground-breaking drug discoveries, the demand for clinical trial imaging will rise, resulting in the growth of imaging CRO.

The imaging CROs is anticipated to grow at a high CAGR in the North American region owing to support from the government regarding favorable regulations and programs that will accelerate the growth. Additionally, the other major factor, which is the presence of major players such as Parexel International, Imaging Endpoints, etc. offers accessibility of clinical trial imaging services, resulting in propelling the growth of the imaging CRO market in the region.

Some of the major players in the global Imaging CRO market include Parexel International Corporation, WORLDCARE CLINICAL, ICON plc, IXICO plc, The Micron Group, WuXi AppTec, Medpace, Labcorp Drug Development, Imaging Endpoints, and Radiant Sage LLC.

Source: VynZ Research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By VynZ Research
Phone 09599764363
Business Address Noida, India, Uttar Pradesh
Country India
Categories Business , Health , Industry
Tags imaging cro , imaging cro market , imaging cro market analysis , imaging cro market growth , imaging cro market share , imaging cro market size , imaging cro market trend , imaging cro market value
Last Updated March 22, 2022